Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 480
Immune Disorders Drugs 201
Drug Discovery 169
Cardiovascular Drugs 159
Infectious Diseases Drugs 138
Biopharmaceuticals 133
Clinical Trials 126
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 84
Hematological Drugs 83
Liver and Kidney Disorders Drugs 81
Lymphoma Drugs 62
Dermatological Drugs 55
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 41
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Pharmaceutical Intermediates 38
Drug Delivery 37
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 33
Infusions and Injectables 30
Liver Cancer Drugs 28
Bladder Cancer Drugs 25
Analgesics 25
Drugs by Therapeutic Area 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Schizophrenia Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Optical Disorders Drugs 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

2,461 Results (Page 51 of 124)
- Relevance
  Sort by

Big Pharma Licensing Trends, 2014-18

 Report
August 2019
82 Pages
Global

€2957EUR$2,995USD£2,470GBP

Immune Thrombocytopenic Purpura Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

 Report
May 2018
88 Pages
Global

From

€2864EUR$2,900USD£2,391GBP

Antipsychotic Drugs Market Analysis & Forecast 2024-2034: Market By Drug; By Therapeutic Class; By Application; By Distribution Channel; and By Region

 Report
October 2023
145 Pages
Global

From

€3110EUR$3,150USD£2,597GBP

Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
October 2022
292 Pages
Global

From

€2469EUR$2,500USD£2,061GBP

Cancer Vaccines Market - Forecasts from 2024 to 2029

 Report
August 2024
135 Pages
Global

From

€3900EUR$3,950USD£3,257GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Investigation Report on the Entecavir Market in China 2020-2024

 Report
September 2020
50 Pages
China

From

€2567EUR$2,600USD£2,144GBP

Type 2 Diabetes Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application

 Report
April 2022
85 Pages
Global

From

€3500EUR$3,797USD£3,025GBP

Market Spotlight: Psoriatic Arthritis

 Report
September 2020
65 Pages
Global

€1301EUR$1,318USD£1,087GBP

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
527 Pages
Global

From

€2469EUR$2,500USD£2,061GBP

Branded Generics Market by Product, Drug Type, Route of Administration, Indication, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
195 Pages
Global

From

€3501EUR$3,545USD£2,923GBP

€3890EUR$3,939USD£3,248GBP

B-Cell Chronic Lymphocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
139 Pages
Global

From

€1975EUR$2,000USD£1,649GBP

Advanced Parenteral Drug Delivery Devices Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Product Type

 Report
February 2022
93 Pages
Global

From

€3200EUR$3,472USD£2,766GBP

Cervical Cancer Treatment Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028

 Report
January 2024
190 Pages
Global

From

€4443EUR$4,500USD£3,710GBP

Graft Versus Host Disease Treatment Market by Disease Type, Product, End-User - Global Forecast 2025-2030

 Report
October 2024
184 Pages
Global

From

€3501EUR$3,545USD£2,923GBP

€3890EUR$3,939USD£3,248GBP

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
42 Pages
Global

From

€3456EUR$3,500USD£2,886GBP

Immunomodulators Market by Product, Application - Global Forecast 2025-2030

 Report
October 2024
191 Pages
Global

From

€3501EUR$3,545USD£2,923GBP

€3890EUR$3,939USD£3,248GBP

Mouth Ulcers Treatment Market by Drug Class, Formulation, End-User - Global Forecast 2025-2030

 Report
October 2024
185 Pages
Global

From

€3501EUR$3,545USD£2,923GBP

€3890EUR$3,939USD£3,248GBP

Human Papillomavirus (HPV) Associated Disorders Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

 Report
October 2023
180 Pages
Global

From

€4443EUR$4,500USD£3,710GBP

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
67 Pages
Global

From

€3456EUR$3,500USD£2,886GBP

Neurofibromatoses Type I (Von Recklinghausen's Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
72 Pages
Global

From

€1975EUR$2,000USD£1,649GBP

2,461 Results (Page 51 of 124)
- 1
- 49
- 50
- 51
- 52
- 53

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.